During 2025, the FDA inspected a tobacco company operating in New Mexico, according to the U.S. Food and Drug Administration (FDA).
This represented the smallest share of inspections by company type conducted by the FDA in New Mexico, accounting for just 2.1% of all inspections that year.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
| Project Area | No Action Indicated | Voluntary Action Indicated | Official Action Indicated |
|---|---|---|---|
| Bioresearch Monitoring | 1 | — | — |
| Blood and Blood Products | 2 | — | — |
| Drug Quality Assurance | — | — | 1 |
| Food Composition, Standards, Labeling and Econ | 17 | 1 | — |
| Foodborne Biological Hazards | 25 | 6 | — |
| Human Cellular, Tissue, and Gene Therapies | 3 | — | — |
| Monitoring of Marketed Animal Drugs, Feed, and Devices | 4 | — | — |
| Technical Assistance: Food and Cosmetics | 8 | — | — |
| Tobacco Post-Market Activities | 1 | — | — |
